Opko Health Stock Is Climbing: What's Going On?
Opko Health Stock Is Climbing: What's Going On?
Opko Health, Inc. (NASDAQ:OPK) shares are trading higher Thursday after the company announced a $100 million share repurchase program.
Opko健康股份有限公司（纳斯达克证券交易所：OPK）股价在周四上涨，公司宣布了一项1亿美元的股票回购计划。
The Details:
细节：
Opko said it expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The company had approximately 697 million shares outstanding as of June 30, 2024, and the new authorization represents approximately 10.1% of shares outstanding at the current stock price.
Opko表示，它预计将从现有的现金及现金等价物和未来现金流中资助回购计划。截至2024年6月30日，公司已经发行约6970万股，新获授权回购的股份约占当前股价的10.1%。
"We believe OPKO's shares are significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO's strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability," said Phillip Frost, M.D., CEO of Opko Health.
Opko健康公司的首席执行官菲利普·弗罗斯特博士（Phillip Frost, M.D.）表示：“我们认为Opko的股份被严重低估并提供了极具吸引力的投资机会。回购股份支持我们对Opko策略的信心，我们将继续在诊所推动我们的管线并使我们的诊断部门走上盈利的道路。”
Additionally, Opko announced a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) after the market close Wednesday. Opko said the purchase agreement is secured by its profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA, a once-weekly treatment to treat pediatric growth hormone deficiency.
此外，Opko在周三收市后宣布，与HealthCare Royalty（HCRx）签订了一项2500万美元的非稀释性票据购买协议。Opko表示，购买协议由其从辉瑞收到的利润分成付款担保，该付款与NGENLA许可协议有关，该协议是一种处理儿童生长激素缺乏症的每周一次治疗方案。
According to data from Benzinga Pro, Opko Health shares are moving on heavy volume and are trading above the stock's 50-day moving average of $1.31.
根据Benzinga Pro的数据，Opko Health股价正在上涨并在高成交量中交易，高于该股票的50日移动平均线1.31美元。
Should I Sell My OPK Stock?
我应该卖掉我的Opko健康股票吗？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在决定持有或出售股票时，投资者应考虑他们的投资期限、未实现收益和总回报。
Shares of Opko Health have decreased by 27.39% in the past year. An investor who bought shares of Opko Health at the beginning of the year would take a loss of $0.03 per share if they sold it today. The stock has risen 24.15% over the past month, meaning an investor who bought shares on June 1 would see a capital gain of $0.12.
过去一年中，Opko Health股价下跌了27.39%。如果投资者在年初购买了Opko Health股票并在今天出售，他们将每股亏损0.03美元。过去一个月，该股上涨了24.15%，这意味着在6月1日购买股票的投资者将获得0.12美元的资本收益。
Opko Health shares have an all-time high of $5.15, representing 234.55% upside from current levels.
Opko Health股价有最高纪录的5.15美元，目前为234.55%的上涨潜力。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Opko Health stock currently has an RSI of 84.21, indicating overbought conditions.
投资者还可以考虑市场动态。相对强度指数可用于指示股票是否超买或超卖。Opko Health股票目前的RSI为84.21，表示超买条件。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
如需高级图表和分析工具以及股票数据，请访问Benzinga Pro。免费试用。
OPK Price Action: According to Benzinga Pro, Opko Health shares are up 3.87% at $1.47 at the time of publication Thursday.
根据Benzinga Pro的数据，Opko Health股价在周四发布时上涨了3.87%，为每股1.47美元。
Read Also:
阅读更多：
- What Happened With Intel Stock Today?
- 英特尔股票今天发生了什么事？
Image: Shutterstock
图片：shutterstock